Unique ID issued by UMIN | UMIN000052295 |
---|---|
Receipt number | R000059705 |
Scientific Title | The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students |
Date of disclosure of the study information | 2023/09/25 |
Last modified on | 2023/09/25 11:56:41 |
The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students
The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students
The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students
The Effects of Acanthopanax senticosus on Anxiety, Motivation to Learn, Sleep Status, and Fatigue Associated with Learning Status in Students
Japan |
male/female adults
Adult |
Others
NO
To evaluate the effect of Acanthopanax senticosus is beneficial for students in terms of motivation to learn and health maintenance.
Efficacy
Others
Others
Not applicable
1.Questionnaires for subjective
2.General Self-efficacy Scale (GSES)
3.OSA sleep inventory
4.STAI
1.salivary amylase
2.salivary cortisol
3.Autonomic activity
4.Objective sleep quality (measured using actigrapgh)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
12-weeks intake of the test food
18 | years-old | <= |
Not applicable |
Male and Female
1.Healty Subjects.
2.Subjects who are males or females and are aged 18 or older.
3.Subjects who have provided written consent for participation in the study.
1.The persons who have taken Acanthopanax Senticosus and are not off it for more than 3 months.
2.Those who regularly use health foods that may affect the study.
3.Allergy to Acanthopanax Senticosus.
4.Subject who is not currently receiving treatment or medication.
5.Subject with current or history of alcohol dependence.
6.Those who are participating in other clinical studies.
7.Subject with severe diseases such as hepatic disorder, kidney disorder, heart disease.
8.Subject who have hepatitis.
9.Severe anemia.
10.Subjects with systolic blood pressure more than 180 mmHg or diastolic blood pressure more than 90 mmHg.
11.Other cases that the principal investigator and subinvestigators deem inappropriate as research subjects.
20
1st name | Fujikawa |
Middle name | |
Last name | Takahiko |
Suzuka University of Medical Science
Faculty of Pharmaceutical Sciences
513-8670
3500-3, Minamitamagaki, Suzuka-city, Mie, 513-8670, JAPAN
059-340-0550
t-fuji@suzuka-u.ac.jp
1st name | Fujishima |
Middle name | |
Last name | Masaki |
Sun Chlorella Corp.
Production & Development Department Research & Development Group
600-8177
369 Osaka-cho, karasumi-dori Gojo-sagaru, shimogyo-ku, Kyoto
075-288-3010
mfujishima@sunchlorella.co.jp
Suzuka University of Medical Science
Suzuka University of Medical Science
Other
Suzuka University of Medical Science
3500-3, Minamitamagaki, Suzuka-city, Mie, 513-8670, JAPAN
059-340-0550
t-fuji@suzuka-u.ac.jp
NO
鈴鹿医療科学大学 / Suzuka University of Medical Science
2023 | Year | 09 | Month | 25 | Day |
Unpublished
Preinitiation
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 10 | Month | 15 | Day |
2024 | Year | 03 | Month | 01 | Day |
2023 | Year | 09 | Month | 25 | Day |
2023 | Year | 09 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059705